New breast cancer drug shows promise for patients in early stages

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

(KPLR) – Promising results about a drug that could help patients in the early stages of breast cancer, a FDA report on the drug “Perjeta” finds it shrinks early-stage breast cancer tumors before surgery.

“Perjeta” was approved last year for breast cancer that has spread to other parts of the body.

Now, drug maker Genentech is seeking approval to use the drug in early-stage treatment of patients with an aggressive and deadly form of the disease.